Assessing causality between inflammatory bowel diseases with frailty index and sarcopenia: a bidirectional Mendelian randomization study
- PMID: 38183088
- PMCID: PMC10768401
- DOI: 10.1186/s40001-023-01614-5
Assessing causality between inflammatory bowel diseases with frailty index and sarcopenia: a bidirectional Mendelian randomization study
Abstract
Background: Previous studies have found that frailty and sarcopenia are commonly diagnosed in inflammatory bowel disease (IBD) patients, indicating an association between these conditions. Nonetheless, the cause‒effect connection between IBD, frailty, and sarcopenia remains unclear.
Methods: We sourced the genetic variants for the exposures and outcomes from publicly accessible, extensive genome-wide association studies (GWAS). Specifically, we obtained IBD data from the International IBD Genetics Consortium, frailty index (FI) data from the United Kingdom Biobank and Swedish TwinGene, and sarcopenia data from a recent GWAS meta-analysis. Five methods, including inverse variance weighted (IVW), simple mode, MR-Egger, weighted mode, and the weighted median, were used to proceed with MR estimates. We also performed heterogeneity and horizontal pleiotropy tests.
Results: Our results indicated a positive causal relationship between ulcerative colitis (UC) (IVW: β = 0.014, 95% CI, 0.006 to 0.021, p = 0.001) and Crohn's disease (CD) (IVW: β = 0.012; 95% CI, 0.006 to 0.018, p = 2e-04) with the FI. However, we uncovered no proof of a cause-and-effect relationship between UC (IVW: β = 0.001, 95% CI, -0.015 to 0.017, p = 0.344) or CD (IVW: β = 0.003, 95% CI, -0.009 to 0.015, p = 0.214) and sarcopenia. Additionally, in the inverse order, we also discovered no cause-and-effect connection between FI or sarcopenia on UC or CD in this study.
Conclusion: The MR analysis showed a positive causal association between IBD and FI, indicating that IBD patients may exhibit aging-related characteristics. Therefore, frailty assessments should be conducted as early as possible in IBD patients.
Keywords: Frailty; Inflammatory bowel disease; Mendelian randomization; Sarcopenia.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Association between inflammatory bowel disease and frailty: a two-sample Mendelian randomization study.Aging Clin Exp Res. 2024 Feb 6;36(1):21. doi: 10.1007/s40520-023-02688-1. Aging Clin Exp Res. 2024. PMID: 38319411 Free PMC article.
-
Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.Front Immunol. 2022 Sep 8;13:956005. doi: 10.3389/fimmu.2022.956005. eCollection 2022. Front Immunol. 2022. PMID: 36159838 Free PMC article.
-
The relationship between inflammatory bowel disease and sarcopenia-related traits: a bidirectional two-sample mendelian randomization study.Front Endocrinol (Lausanne). 2024 Jul 12;15:1402551. doi: 10.3389/fendo.2024.1402551. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39072277 Free PMC article.
-
A Bidirectional Mendelian Randomization Study of Sarcopenia-Related Traits and Knee Osteoarthritis.Clin Interv Aging. 2023 Sep 15;18:1577-1586. doi: 10.2147/CIA.S424633. eCollection 2023. Clin Interv Aging. 2023. PMID: 37731961 Free PMC article. Review.
-
Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence.JGH Open. 2024 Jan 27;8(1):e13033. doi: 10.1002/jgh3.13033. eCollection 2024 Jan. JGH Open. 2024. PMID: 38283070 Free PMC article. Review.
Cited by
-
Standardizing trait selection in Mendelian randomization studies concerning sarcopenia.J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1220-1221. doi: 10.1002/jcsm.13463. Epub 2024 Mar 23. J Cachexia Sarcopenia Muscle. 2024. PMID: 38520252 Free PMC article. No abstract available.
-
A Comprehensive Review of Geriatric Syndromes and Assessment in Older Adults With Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol. 2025 Jun;23(7):1088-1101. doi: 10.1016/j.cgh.2024.09.042. Epub 2025 Mar 11. Clin Gastroenterol Hepatol. 2025. PMID: 40081635
References
-
- GBD 2017 Inflammatory Bowel Disease Collaborators The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi: 10.1016/S2468-1253(19)30333-4. - DOI - PMC - PubMed
-
- Saltzman JR, Russell RM. Nutritional consequences of intestinal bacterial overgrowth. Compr Ther. 1994;20(9):523–530. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources